IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q3 2025 Holdings

Filed 2025-11-13 | 10 holdings | $173.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte Inc(PCVX)COM92243G108$49.4M1,372,42528.6%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$40.4M2,300,77423.4%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$40.0M2,120,50823.1%
Zenas Biopharma Inc(ZBIO)COM98937L105$17.3M779,04510.0%
Trevi Therapeutics Inc(TRVI)COM89532M101$11.5M1,256,7826.6%
Immunome Inc(IMNM)COM45257U108$5.9M502,5123.4%
Bioage Labs Inc(BIOA)COM09077V100$3.8M653,3742.2%
Recursion Pharmaceuticals in(RXRX)CL A75629V104$2.9M595,5181.7%
Rallybio CorpCOM75120L100$1.2M2,404,6440.7%
Bolt Biotherapeutics Inc(BOLT)COM NEW097702203$503.1K94,5730.3%